Literature DB >> 7843759

Blood pressure after captopril withdrawal from spontaneously hypertensive rats.

C K Kost1, P Li, E K Jackson.   

Abstract

The purpose of the present study was to compare the effect of chronic captopril treatment on blood pressure in young and adult spontaneously hypertensive rats (SHR) and to assess the time course for development of hypertension after captopril withdrawal. SHR received drinking water or captopril solution from 4 weeks of age and were instrumented with radiotelemetry devices at 18 weeks of age to allow continuous monitoring of blood pressure. At 23 weeks of age, mean blood pressure in the captopril group was 100 +/- 1 mm Hg compared with 157 +/- 3 mm Hg in the water group. Pulse pressure also was significantly reduced in the captopril-treated rats. Infusion of angiotensin II into a subset of captopril-treated rats increased pulse pressure and restored blood pressure to levels of water-treated rats. Captopril treatment for 6 weeks in adult, 24-week-old SHR did not reduce blood pressure to the level of rats treated from 4 weeks of age. Ten weeks after cessation of captopril, blood pressure was 125 +/- 4 and 144 +/- 4 mm Hg in SHR treated with captopril from 4 to 30 and from 24 to 30 weeks of age, respectively, compared with control hypertensive rats with mean blood pressure of 160 +/- 6 mm Hg. Results from this radiotelemetry study confirm previous findings that captopril treatment prevents the development of hypertension and produces a persistent reduction of blood pressure after treatment in young SHR. Captopril treatment produced a persistent reduction of blood pressure after discontinuation in adult rats; however, the effect was less than that observed with captopril initiated in young rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843759     DOI: 10.1161/01.hyp.25.1.82

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  4 in total

1.  Sustained Captopril-Induced Reduction in Blood Pressure Is Associated With Alterations in Gut-Brain Axis in the Spontaneously Hypertensive Rat.

Authors:  Tao Yang; Victor Aquino; Gilberto O Lobaton; Hongbao Li; Luis Colon-Perez; Ruby Goel; Yanfei Qi; Jasenka Zubcevic; Marcelo Febo; Elaine M Richards; Carl J Pepine; Mohan K Raizada
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

2.  DPP4 Inhibition, NPY1-36, PYY1-36, SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol.

Authors:  Edwin K Jackson; Delbert G Gillespie; Stevan P Tofovic
Journal:  J Pharmacol Exp Ther       Date:  2020-02-03       Impact factor: 4.030

3.  Antihypertensive and cardioprotective effects of different monotherapies and combination therapies in young spontaneously hypertensive rats - A pilot study.

Authors:  Christina Hawlitschek; Julia Brendel; Philipp Gabriel; Katrin Schierle; Aida Salameh; Heinz-Gerd Zimmer; Beate Rassler
Journal:  Saudi J Biol Sci       Date:  2021-09-08       Impact factor: 4.219

4.  How Effective Is a Late-Onset Antihypertensive Treatment? Studies with Captopril as Monotherapy and in Combination with Nifedipine in Old Spontaneously Hypertensive Rats.

Authors:  Christina Hawlitschek; Julia Brendel; Philipp Gabriel; Katrin Schierle; Aida Salameh; Heinz-Gerd Zimmer; Beate Rassler
Journal:  Biomedicines       Date:  2022-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.